DHFRL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.958780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.368000E-01
Normal-vs-Stage2
1.450240E-01
Normal-vs-Stage3
2.431900E-02
Normal-vs-Stage4
9.820600E-01
Stage1-vs-Stage2
8.988100E-02
Stage1-vs-Stage3
1.681890E-02
Stage1-vs-Stage4
8.797800E-01
Stage2-vs-Stage3
1.102570E-01
Stage2-vs-Stage4
1.080570E-01
Stage3-vs-Stage4
1.275640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.817630E-01
Normal-vs-AfricanAmerican
6.062800E-01
Normal-vs-Asian
1.161220E-01
Caucasian-vs-AfricanAmerican
2.972200E-01
Caucasian-vs-Asian
3.691400E-01
AfricanAmerican-vs-Asian
1.577170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.465640E-01
Normal-vs-Female
2.776000E-01
Male-vs-Female
3.599600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.339400E-01
Normal-vs-Age(41-60Yrs)
3.334800E-01
Normal-vs-Age(61-80Yrs)
1.757980E-01
Normal-vs-Age(81-100Yrs)
4.859800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.876800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.095600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.271600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.971990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.070100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.063800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.156500E-02
Normal-vs-Daily Drinker
3.369700E-02
Normal-vs-Weekly Drinker
1.104950E-01
Normal-vs-Occasional Drinker
4.134200E-01
Normal-vs-Social Drinker
3.886200E-01
Non Drinker-vs-Daily Drinker
8.827400E-01
Non Drinker-vs-Weekly Drinker
7.978000E-01
Non Drinker-vs-Occasional Drinker
1.482240E-01
Non Drinker-vs-Social Drinker
7.274200E-02
Daily Drinker-vs-Weekly Drinker
8.928800E-01
Daily Drinker-vs-Occasional Drinker
1.837030E-01
Daily Drinker-vs-Social Drinker
1.081190E-01
Weekly Drinker-vs-Occasional Drinker
3.096800E-01
Weekly Drinker-vs-Social Drinker
2.406800E-01
Occasional Drinker-vs-Social Drinker
9.222600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.440400E-02
Normal-vs-Grade 2
1.682320E-02
Normal-vs-Grade 3
1.724380E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.024200E-01
Grade 1-vs-Grade 3
9.943400E-01
Grade 1-vs-Grade 4
4.440400E-02
Grade 2-vs-Grade 3
7.678200E-01
Grade 2-vs-Grade 4
1.682320E-02
Grade 3-vs-Grade 4
1.724380E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.420300E-02
Normal-vs-NonDiabetic
1.164570E-01
Diabetic-vs-NonDiabetic
4.233000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.193900E-02
Normal-vs-NoPancreatitis
1.284960E-01
Pancreatitis-vs-NoPancreatitis
1.688780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.590400E-01
Normal-vs-N1
1.428610E-01
N0-vs-N1
5.508800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.842200E-01
Normal-vs-TP53-NonMutant
7.069800E-01
TP53-Mutant-vs-TP53-NonMutant
3.206800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
